The producer believes it is no longer financially feasible to produce Panadol and has been pleading with authorities to increase drug prices.
The Drug Regulatory Authority of Pakistan (DRAP) reportedly sent a summary to the health ministry asking for an increase of Rs 1 per tablet. But the federal cabinet rejected the document, according to the Pharmaceutical Manufacturing Association of Pakistan.
According to the association, the producer could not sell the medication for less than it cost to produce.
The pharmaceutical industry claims that all tablet production has come to an end.